ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 175 filers reported holding ANTARES PHARMA INC in Q4 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $899,000 | -18.5% | 219,328 | -27.6% | 0.00% | 0.0% |
| Q3 2021 | $1,103,000 | +20.4% | 303,128 | -10.6% | 0.00% | 0.0% |
| Q3 2020 | $916,000 | +40.3% | 339,213 | +42.8% | 0.00% | 0.0% |
| Q2 2020 | $653,000 | -79.8% | 237,528 | -82.6% | 0.00% | -66.7% |
| Q1 2020 | $3,225,000 | -40.1% | 1,366,614 | +19.4% | 0.00% | -25.0% |
| Q4 2019 | $5,380,000 | +1154.1% | 1,144,707 | +793.4% | 0.00% | – |
| Q3 2019 | $429,000 | -59.8% | 128,128 | -60.5% | 0.00% | -100.0% |
| Q2 2019 | $1,067,000 | -14.7% | 324,328 | -21.4% | 0.00% | 0.0% |
| Q1 2019 | $1,251,000 | +4.8% | 412,828 | -31.2% | 0.00% | 0.0% |
| Q4 2017 | $1,194,000 | -86.8% | 599,769 | -78.5% | 0.00% | -90.9% |
| Q3 2017 | $9,020,000 | -19.1% | 2,783,991 | -19.6% | 0.01% | -21.4% |
| Q2 2017 | $11,149,000 | +24.5% | 3,462,469 | +9.8% | 0.01% | +7.7% |
| Q1 2017 | $8,953,000 | +34.4% | 3,152,569 | +10.3% | 0.01% | +18.2% |
| Q4 2016 | $6,662,000 | +48.3% | 2,859,341 | +6.9% | 0.01% | +37.5% |
| Q3 2016 | $4,493,000 | +57.4% | 2,674,341 | -1.6% | 0.01% | +60.0% |
| Q2 2016 | $2,854,000 | +47.0% | 2,717,852 | +21.8% | 0.01% | +25.0% |
| Q1 2016 | $1,941,000 | +15.8% | 2,231,169 | +61.0% | 0.00% | 0.0% |
| Q4 2015 | $1,676,000 | +241.3% | 1,385,438 | +379.3% | 0.00% | +300.0% |
| Q3 2015 | $491,000 | +28.9% | 289,041 | +58.0% | 0.00% | 0.0% |
| Q2 2015 | $381,000 | +72.4% | 182,941 | +112.8% | 0.00% | 0.0% |
| Q4 2014 | $221,000 | -17.2% | 85,970 | -41.0% | 0.00% | 0.0% |
| Q3 2014 | $267,000 | – | 145,728 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|